- Home
- >
- Industries
- >
- Biologics
Regulatory & Compliance Services for Biologics
We help biologics companies meet global regulatory, safety, and quality standards across every stage of the product lifecycle. From registration to compliance and ongoing market support, Artixio brings deep expertise across 120+ countries.
Specialized Regulatory Support for Biologics
Biologics come with unique regulatory challenges—complex development processes, sensitive handling, and strict safety expectations. At Artixio, we work closely with biologics manufacturers, innovators, and distributors to manage everything from early-stage regulatory planning to post-market compliance. Our services cover product registration, dossier preparation, regulatory submissions, lifecycle management, and pharmacovigilance support. Whether it’s biosimilars, cell and gene therapies, or recombinant products, we bring region-specific expertise across 120+ markets. Artixio ensures your biologics stay compliant, market-ready, and audit-ready at every stage.
Why Biologics Clients Choose Artixio

100+ biologics projects delivered

Centralized project tracking system

Global team with local expertise

15–35 years biologics expertise

End-to-end regulatory lifecycle support

Proven record with 50+ health authorities

Digitally enabled regulatory operations

Founded on ISO 9001:2015 quality standards
Regulatory Process for Biologics
- Early Regulatory Planning
- Dossier Development & Submission
- Clinical Trial Approvals
- Product Registration
- Marketing Authorization Applications
- Post-Approval Maintenance
- Pharmacovigilance & Risk Management
Artixio’s Key Focus Areas for Biologics
- Cell & gene therapy compliance
- Biosimilars regulatory consulting
- Labeling & packaging compliance
- Pharmacovigilance & risk planning
- GxP audits & QMS setup
- Regulatory intelligence reporting
- Import/export & borderline classification
Regulatory Expertise Across
Multiple Countries












Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in
Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

UK Releases Amendment &
In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

Artixio Announces Grant for
HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...